Schedule of deferred tax assets |
|
|
March 31, |
|
|
|
2019 |
|
|
2018 |
|
Deferred tax assets: |
|
|
|
|
|
|
|
|
Net operating loss carryforwards |
|
$ |
28,118,000 |
|
|
$ |
25,487,000 |
|
Research and development tax credit carryforwards |
|
|
1,850,000 |
|
|
|
1,789,000 |
|
Stock-based compensation |
|
|
3,795,000 |
|
|
|
3,697,000 |
|
Allowances and accruals |
|
|
1,142,000 |
|
|
|
1,118,000 |
|
Other deferred tax assets |
|
|
252,000 |
|
|
|
284,000 |
|
State income taxes |
|
|
1,000 |
|
|
|
1,000 |
|
Basis difference in assets |
|
|
14,000 |
|
|
|
(3,000 |
) |
Total deferred tax assets |
|
$ |
35,172,000 |
|
|
$ |
32,373,000 |
|
|
|
|
|
|
|
|
|
|
Deferred tax assets |
|
|
35,172,000 |
|
|
|
32,373,000 |
|
Valuation allowance |
|
|
(35,172,000 |
) |
|
|
(32,373,000 |
) |
Deferred tax assets |
|
$ |
– |
|
|
$ |
– |
|
|
Income tax provision domestic and foreign |
|
|
|
Year Ended March 31, |
|
|
|
|
2019 |
|
|
2018 |
|
|
Domestic |
|
|
$ |
10,088,000 |
|
|
$ |
12,607,000 |
|
|
Foreign |
|
|
|
1,252,000 |
|
|
|
1,671,000 |
|
|
|
|
|
$ |
11,340,000 |
|
|
$ |
14,278,000 |
|
|
Schedule of income tax expense |
|
|
|
Year Ended March 31, |
|
|
|
|
2019 |
|
|
2018 |
|
Current: |
|
|
|
|
|
|
|
State |
|
|
$ |
2,000 |
|
|
$ |
37,000 |
|
Foreign |
|
|
|
456,000 |
|
|
|
13,000 |
|
|
|
|
|
458,000 |
|
|
|
50,000 |
|
Deferred: |
|
|
|
|
|
|
|
|
|
Federal |
|
|
|
– |
|
|
|
– |
|
State |
|
|
|
– |
|
|
|
– |
|
Foreign |
|
|
|
– |
|
|
|
– |
|
|
|
|
$ |
458,000 |
|
|
$ |
50,000 |
|
|